Diaceutics PLC (LON:DXRX)
145p
Spriggl Score: Good— sign in to explore; full breakdown with Premium
Last 30 trading days
Spriggl AI Verdict
“Precision-medicine data provider turns profitable with surging orders; high valuation demands sustained US growth.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About Diaceutics PLC
Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies. The company offers DXRX, a diagnostic commercialization platform for precision medicine that integrates multiple pipelines of diagn…
- Sector:
- Healthcare
- Industry:
- Health Information Services
- Market Cap:
- £123.4M
Recent dividends
No recent dividends recorded.
Get the full Spriggl analysis — free
A free Spriggl account gets you the screener, a watchlist, AI verdicts and a free full report every day — across Diaceutics PLC and 1,500+ UK and US stocks. The full score breakdown and AI analysis come with Premium.
Start free